Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Khushnood Sheikh"'
Publikováno v:
National Journal of Community Medicine, Vol 7, Iss 01 (2016)
Introduction: On the basis of development in vitrectomy procedure a whole new subspecialty termed vitreoretinal surgery has evolved over past 30 years. We conducted this study to evaluate usefulness and necessity of Pars plana vitrectomy in today’s
Externí odkaz:
https://doaj.org/article/edc6add9fbd948dcbef43432659a119f
Publikováno v:
Indian Journal of Forensic and Community Medicine. 10:38-45
An upward rise has been observed in the pattern of unnatural deaths in the recent years and the same has been found during the post mortem examination. During the trial in the court of law prosecution as well as defense require the time passed death
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cdaca2c02ad5144be7d834a3b7ad46ec
https://doi.org/10.18231/j.ijfcm.2023.007
https://doi.org/10.18231/j.ijfcm.2023.007
Publikováno v:
Indian Journal of Clinical and Experimental Ophthalmology. 6:282-285
Retinopathy of prematurity (ROP) is a disorder seen in preterm babies. ROP is a potentially preventable cause of irreversible total blindness in premature infants. Recent advancements in neonatal care have led to an increase in the survival of low bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b547fa3b74bb222b6867ca39f0a229bd
https://doi.org/10.18231/j.ijceo.2020.061
https://doi.org/10.18231/j.ijceo.2020.061
Publikováno v:
Indian Journal of Clinical and Experimental Ophthalmology. 5:457-460
Since many years anesthesia for an eye evolving from retrobulbar to topical. Hyaluronidase is use for better absorption of anesthetic solution. Due to the enzyme nature of hyaluronidase, cost of the drug, risk of anaphylaxis and limited shelf life le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::343f692a55ecd3037cfb32aed9cbdd7c
https://doi.org/10.18231/j.ijceo.2019.109
https://doi.org/10.18231/j.ijceo.2019.109